Developer docs
API playgroundTry for free, no card

Search company profiles

Grupo Procaps

Full company profile

uuid004j853

Namestring
Grupo Procaps
Legal namestring
Procaps, S.A.
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Grupo Procaps (legal entity Procaps, S.A.) is a Colombia-based pharmaceutical group operating across 11 Latin American countries. The company develops, manufactures, and markets pharmaceutical products through four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (highly complex hospital medicines for critical processing), Vital Care (over-the-counter and generic health products for family wellness), and Diabetrics (well-being and chronic-condition management solutions for people with diabetes and their caregivers). The portfolio is extended to consumers through branded portals such as Diabetrics.com, gumivit.com.co, and dolofen.com.co.

The company runs a multi-channel go-to-market model combining direct sales to hospitals and healthcare providers for Clinical Specialities products, retail and pharmacy distribution for OTC and generic products across 11 Latin American countries, and direct-to-consumer e-commerce through its brand portals. Brand engagement is supported by an active presence on Twitter/X (@GrupoProcaps), LinkedIn, Instagram (@procapslatam), and YouTube (@ProcapsLatam). The company operates as a private entity (no public ticker, exchange listing, or disclosed parent), and explicitly disclaims any U.S. operations or affiliation with the U.S.-based ProCaps Laboratories.

Key data gaps relevant to investment analysis: no revenue or financial figures are disclosed; the listed headcount of 25 in the firmographics header is inconsistent with the breadth of operations and the headcount array is empty; no management team, ownership structure, funding history, M&A activity, patents, trademarks, or certifications are disclosed in the available data, despite the website referencing a certifications page; and no AI/ML capabilities or API/SDK offerings are documented. These gaps materially limit confidence in any quantitative assessment.

Short descriptiontext

Grupo Procaps (Procaps, S.A.) is a Colombia-based pharmaceutical group that develops, manufactures, and markets prescription, hospital, OTC, and diabetes-care medicines across 11 Latin American countries through four therapeutic lines.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRegional Presence
HQ citystring
Regional Presence
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, prescription medicines, hospital medicines, OTC generics, diabetes care
Industry3 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Procaps generates revenue through the development, manufacture, and marketing of pharmaceutical products across four therapeutic lines: Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes wellness products).

procapslatam.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Diabetrics
Description

Well-being and quality of life services for people with diabetes (PWD), providing chronic condition management support.

procapslatam.com
+5 more records
Core offering1 text field

Grupo Procaps develops, manufactures, and markets pharmaceutical products across Latin America, operating four therapeutic lines: prescription brand medicines (Farma), complex hospital medicines (Clinical Specialities), OTC and generic health products (Vital Care), and diabetes management solutions (Diabetrics). The company operates in 11 Latin American countries and distributes through retail pharmacies, direct hospital sales, and brand e-commerce portals such as Gumivit and Dolofen.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Grupo Procaps is a pharmaceutical company organized around four core therapeutic lines—Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions)—which together form a unified portfolio addressing both prescription and consumer health needs. The company also maintains branded product portals including Gumivit (gum and vitamin products) and Dolofen (pain relief), extending its consumer reach through dedicated digital channels.

Product and service1 record
1Farma
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global pharmaceutical major with established diabetes (Lantus, Toujeo) and consumer health franchises across Latin America. Comparable to Procaps in primary care prescription and diabetes therapeutic areas, and a key competitor in Diabetrics.

2Laboratorios Tecnoquímicas
TypeRegional player
Description

Colombian pharmaceutical manufacturer of OTC and personal care products primarily serving Colombia and select Andean markets. Comparable in geographic anchor (Colombia) and consumer health (OTC/generic) therapeutic mix.

3Laboratorios Pisa
TypeDirect peer
Description

Mexican pharmaceutical manufacturer with focus on generic, branded generic, and hospital products distributed across Latin America. Comparable to Procaps' generics, hospital specialty, and multi-country LatAm operations.

TypeDirect peer
Description

Mexican pharmaceutical company focused on OTC and personal care products marketed across Latin America. Comparable to Procaps' Vital Care (OTC) and Diabetrics (consumer chronic care) consumer health lines and shared multi-country LatAm distribution model.

5Grupo EMS
TypeDirect peer
Description

Largest pharmaceutical company in Brazil, manufacturing branded prescription, generic, OTC, and hospital products across Latin America. Directly comparable to Grupo Procaps in therapeutic line breadth, manufacturing footprint, and mass-market regional reach.

TypeDirect peer
Description

Argentine pharmaceutical group with presence across Latin America manufacturing prescription, hospital, and OTC products. Comparable to Procaps in multi-country LatAm manufacturing, therapeutic line structure, and emphasis on branded prescription medicines.

7Eurofarma Laboratórios
TypeDirect peer
Description

Brazilian multinational pharmaceutical company with operations across Latin America producing branded generics, prescription medicines, OTC, and hospital products. Closely comparable to Procaps in product mix (Rx, OTC, hospital) and multi-country LatAm presence.

TypeDirect peer
Description

Brazilian pharmaceutical company with branded generics, prescription, and OTC product portfolio sold across Latin America. Comparable to Procaps in prescription and OTC therapeutic mix plus regional LatAm footprint.

9Laboratorios Richmond
TypeDirect peer
Description

Argentine pharmaceutical laboratory manufacturing branded and generic products across multiple therapeutic areas with Latin American distribution. Comparable to Procaps in branded prescription medicines and multi-country LatAm reach.

TypeOthers
Description

Switzerland-based pharmaceutical manufacturer with strong presence in Latin America producing branded prescription medicines and generics. Comparable to Procaps as a manufacturer of branded prescription pharmaceuticals with multi-country LatAm distribution.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grupo Procaps

Pharmaceutical Manufacturinggrupoprocaps.com

Grupo Procaps (Procaps, S.A.) is a Colombia-based pharmaceutical group that develops, manufactures, and markets prescription, hospital, OTC, and diabetes-care medicines across 11 Latin American countries through four therapeutic lines.

What Grupo Procaps does

Grupo Procaps (legal entity Procaps, S.A.) is a Colombia-based pharmaceutical group operating across 11 Latin American countries. The company develops, manufactures, and markets pharmaceutical products through four therapeutic lines: Farma (exclusive prescription brand medicines), Clinical Specialities (highly complex hospital medicines for critical processing), Vital Care (over-the-counter and generic health products for family wellness), and Diabetrics (well-being and chronic-condition management solutions for people with diabetes and their caregivers). The portfolio is extended to consumers through branded portals such as Diabetrics.com, gumivit.com.co, and dolofen.com.co.

The company runs a multi-channel go-to-market model combining direct sales to hospitals and healthcare providers for Clinical Specialities products, retail and pharmacy distribution for OTC and generic products across 11 Latin American countries, and direct-to-consumer e-commerce through its brand portals. Brand engagement is supported by an active presence on Twitter/X (@GrupoProcaps), LinkedIn, Instagram (@procapslatam), and YouTube (@ProcapsLatam). The company operates as a private entity (no public ticker, exchange listing, or disclosed parent), and explicitly disclaims any U.S. operations or affiliation with the U.S.-based ProCaps Laboratories.

Key data gaps relevant to investment analysis: no revenue or financial figures are disclosed; the listed headcount of 25 in the firmographics header is inconsistent with the breadth of operations and the headcount array is empty; no management team, ownership structure, funding history, M&A activity, patents, trademarks, or certifications are disclosed in the available data, despite the website referencing a certifications page; and no AI/ML capabilities or API/SDK offerings are documented. These gaps materially limit confidence in any quantitative assessment.

Grupo Procaps firmographics

Firmographics
Name
Grupo Procaps
Legal name
Procaps, S.A.
Website
https://grupoprocaps.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Grupo Procaps (Procaps, S.A.) is a Colombia-based pharmaceutical group that develops, manufactures, and markets prescription, hospital, OTC, and diabetes-care medicines across 11 Latin American countries through four therapeutic lines.
Ownership category
akta.pro rank

Grupo Procaps industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAE
Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Pharmaceutical products
  • Prescription medicines
  • Hospital medicines
  • OTC generics
  • Diabetes care

Where Grupo Procaps is headquartered

Location

Headquarters

HQ city
Regional Presence

Offices1 record

Markets served

Grupo Procaps business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Pharmaceutical Product Sales: Procaps generates revenue through the development, manufacture, and marketing of pharmaceutical products across four therapeutic lines: Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes wellness products).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Grupo Procaps product offering

Product offering

Core offering

Grupo Procaps develops, manufactures, and markets pharmaceutical products across Latin America, operating four therapeutic lines: prescription brand medicines (Farma), complex hospital medicines (Clinical Specialities), OTC and generic health products (Vital Care), and diabetes management solutions (Diabetrics). The company operates in 11 Latin American countries and distributes through retail pharmacies, direct hospital sales, and brand e-commerce portals such as Gumivit and Dolofen.

Product overview

Grupo Procaps is a pharmaceutical company organized around four core therapeutic lines—Farma (prescription brand medicines), Clinical Specialities (complex hospital medicines), Vital Care (OTC and generic health products), and Diabetrics (diabetes management solutions)—which together form a unified portfolio addressing both prescription and consumer health needs. The company also maintains branded product portals including Gumivit (gum and vitamin products) and Dolofen (pain relief), extending its consumer reach through dedicated digital channels.

Differentiator

Problem solved

Functional benefit

Brands

  • Diabetrics: Well-being and quality of life services for people with diabetes (PWD), providing chronic condition management support.
  • Farma
  • Clinical Specialities
  • Vital Care
  • Gumivit
  • Dolofen

Products and services

  • Farma

Companies that use Grupo Procaps

Customer profile

Segments4 records

Ideal customer profiles3 records

Grupo Procaps technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Grupo Procaps partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Grupo Procaps competitors and assessment

Company assessment

Broad incumbents

  • Sanofi: Global pharmaceutical major with established diabetes (Lantus, Toujeo) and consumer health franchises across Latin America. Comparable to Procaps in primary care prescription and diabetes therapeutic areas, and a key competitor in Diabetrics.

Regional players

  • Laboratorios Tecnoquímicas: Colombian pharmaceutical manufacturer of OTC and personal care products primarily serving Colombia and select Andean markets. Comparable in geographic anchor (Colombia) and consumer health (OTC/generic) therapeutic mix.

Direct peers

  • Laboratorios Pisa: Mexican pharmaceutical manufacturer with focus on generic, branded generic, and hospital products distributed across Latin America. Comparable to Procaps' generics, hospital specialty, and multi-country LatAm operations.
  • Genomma Lab Internacional: Mexican pharmaceutical company focused on OTC and personal care products marketed across Latin America. Comparable to Procaps' Vital Care (OTC) and Diabetrics (consumer chronic care) consumer health lines and shared multi-country LatAm distribution model.
  • Grupo EMS: Largest pharmaceutical company in Brazil, manufacturing branded prescription, generic, OTC, and hospital products across Latin America. Directly comparable to Grupo Procaps in therapeutic line breadth, manufacturing footprint, and mass-market regional reach.
  • Laboratorios Bagó: Argentine pharmaceutical group with presence across Latin America manufacturing prescription, hospital, and OTC products. Comparable to Procaps in multi-country LatAm manufacturing, therapeutic line structure, and emphasis on branded prescription medicines.
  • Eurofarma Laboratórios: Brazilian multinational pharmaceutical company with operations across Latin America producing branded generics, prescription medicines, OTC, and hospital products. Closely comparable to Procaps in product mix (Rx, OTC, hospital) and multi-country LatAm presence.
  • Aché Laboratórios Farmacêuticos: Brazilian pharmaceutical company with branded generics, prescription, and OTC product portfolio sold across Latin America. Comparable to Procaps in prescription and OTC therapeutic mix plus regional LatAm footprint.
  • Laboratorios Richmond: Argentine pharmaceutical laboratory manufacturing branded and generic products across multiple therapeutic areas with Latin American distribution. Comparable to Procaps in branded prescription medicines and multi-country LatAm reach.

Others

  • Laboratorios Siegfried: Switzerland-based pharmaceutical manufacturer with strong presence in Latin America producing branded prescription medicines and generics. Comparable to Procaps as a manufacturer of branded prescription pharmaceuticals with multi-country LatAm distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Grupo Procaps social profiles

Digital presence

Grupo Procaps financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grupo Procaps leadership team

Management profile

Number of profiles

Grupo Procaps funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grupo Procaps M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grupo Procaps

What does Grupo Procaps do?

Grupo Procaps develops, manufactures, and markets pharmaceutical products across Latin America, operating four therapeutic lines: prescription brand medicines (Farma), complex hospital medicines (Clinical Specialities), OTC and generic health products (Vital Care), and diabetes management solutions (Diabetrics). The company operates in 11 Latin American countries and distributes through retail pharmacies, direct hospital sales, and brand e-commerce portals such as Gumivit and Dolofen.

Is Grupo Procaps a public or private company?

Grupo Procaps is a private company. It is classified as unknown and is currently operating.

When was Grupo Procaps founded?

Grupo Procaps was founded in -1. It employs 11 to 50 people.

Where is Grupo Procaps based?

Grupo Procaps is headquartered in Regional Presence.

How does Grupo Procaps make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Grupo Procaps's main competitors?

Sanofi is listed as a broad incumbent. Laboratorios Tecnoquímicas is listed as a regional player. Direct peers are Laboratorios Pisa, Genomma Lab Internacional, Grupo EMS, Laboratorios Bagó, Eurofarma Laboratórios, Aché Laboratórios Farmacêuticos and Laboratorios Richmond. Laboratorios Siegfried is listed as an others.

Does Grupo Procaps have an API?

No public API is recorded for Grupo Procaps.

What industry is Grupo Procaps in?

Grupo Procaps's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals